March 19 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its blockbuster weight-loss drug Wegovy. The ...

The FDA has approved a new higher-dose version of injectable semaglutide (Wegovy HD, Novo Nordisk) for both weight loss and long-term weight-loss maintenance. The higher dose, 7.2 mg, produced an ...

Mexico's government said Thursday it had seized 14 million doses of fentanyl, the latest major haul in a drive to stem the flow of the powerful opioid into the United States. The Public Security ...

FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Many challenges face developers of drugs for rare diseases, including the small number of patients available for clinical trials, genotypic and phenotypic diversity within a disorder, poorly ...

President Trump boasted proudly of his work on lowering drug costs during his State of the Union address on Tuesday, holding up his “most favored nation” (MFN) policy and TrumpRx.gov as proof of ...

Feb 23 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Credit: Lilly. The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions. The device is for single-patient use only and should never be ...

Food and Drug Administration Commissioner Marty Makary told CNBC that his view is that "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring. He said the ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A medication that has been prescribed in the U.S. for decades may be able to stop the earliest steps of Alzheimer’s ...